<p>银背生物科技公司（NASDAQ:SBTX - 获取免费报告）在周一的午盘交易中下跌了 6.9%。该公司的股价最低曾达到 11.89 美元，最后交易价为 11.92 美元。在午盘交易中，约有 1,370,275 股成交，较平均每日成交量 337,931 股增加了 305%。该股票此前收盘价为 12.80 美元。</p>
<h2>银背生物科技股票下跌 6.9%</h2>
<p>该公司的市值为 4.2981 亿美元，市盈率为-4.93，贝塔值为 0.60。该股票的 50 日简单移动平均线为 12.32 美元，200 日简单移动平均线为 13.07 美元。</p>
<h2>银背生物科技公司简介</h2>
<p>（获取免费报告）</p>
<p>银背生物科技公司是一家生物制药公司，开发针对慢性病毒感染、癌症和其他严重疾病的组织靶向治疗药物。该公司提供 SBT8230，用于通过靶向 TLR8 激活到肝脏，诱导抗病毒免疫反应来治疗慢性乙型肝炎病毒感染。</p>
<h2>精选故事</h2>
<ul>
<li>五只我们更看好的股票超过银背生物科技</li>
<li>TSX 风险投资交易所（前身为加拿大风险投资交易所）</li>
<li>默克：购买此跌幅的四个不容错过的理由</li>
<li>寻找并盈利交易 52 周低点的股票</li>
<li>阿克曼宣布在优步的重大股份：你应该跟随他的脚步吗？</li>
<li>FAANG 股票是什么，它们是好的投资吗？</li>
<li>富国银行升级了这三只股票——它们为何脱颖而出</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如有任何问题或意见，请发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1000 美元吗？</h2>
<p>在你进行下一笔交易之前，你会想听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。</p>
<p>我们的团队已确定五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而且没有大名鼎鼎的股票在名单上。</p>
<p>他们认为这五只股票是投资者现在购买的五家最佳公司……</p>
<p>查看这五只股票</p>
<h2>你现在应该投资 1000 美元在银背生物科技吗？</h2>
<p>在你考虑银背生物科技之前，你会想听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已确定五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而银背生物科技并不在名单上。</p>
<p>虽然银背生物科技目前在分析师中有 “持有” 评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

SBTX

<p>银背治疗公司（NASDAQ:SBTX）股价在午盘交易中下跌 6.9%，至 11.92 美元，交易量较平均水平增加了 305%。该公司的市值为 4.2981 亿美元，市盈率为-4.93。分析师目前对该股票的评级为 “持有”，但建议有更好的投资选择。银背治疗专注于开发针对慢性病毒感染和癌症的治疗药物</p>

<p>Silverback Therapeutics, Inc. (NASDAQ:SBTX - Get Free Report) was down 6.9% during mid-day trading on Monday . The company traded as low as $11.89 and last traded at $11.92. Approximately 1,370,275 shares traded hands during mid-day trading, an increase of 305% from the average daily volume of 337,931 shares. The stock had previously closed at $12.80.</p>
<div class="lb-trans"><p>银背生物科技公司（NASDAQ:SBTX - 获取免费报告）在周一的午盘交易中下跌了 6.9%。该公司的股价最低曾达到 11.89 美元，最后交易价为 11.92 美元。在午盘交易中，约有 1,370,275 股成交，较平均每日成交量 337,931 股增加了 305%。该股票此前收盘价为 12.80 美元。</p>
</div><h2>Silverback Therapeutics Stock Down 6.9 %</h2>
<div class="lb-trans"><h2>银背生物科技股票下跌 6.9%</h2>
</div><p>The company has a market capitalization of $429.81 million, a price-to-earnings ratio of -4.93 and a beta of 0.60. The stock has a 50 day simple moving average of $12.32 and a 200 day simple moving average of $13.07.</p>
<div class="lb-trans"><p>该公司的市值为 4.2981 亿美元，市盈率为-4.93，贝塔值为 0.60。该股票的 50 日简单移动平均线为 12.32 美元，200 日简单移动平均线为 13.07 美元。</p>
</div><h2>Silverback Therapeutics Company Profile</h2>
<div class="lb-trans"><h2>银背生物科技公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Silverback Therapeutics, Inc, a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver.</p>
<div class="lb-trans"><p>银背生物科技公司是一家生物制药公司，开发针对慢性病毒感染、癌症和其他严重疾病的组织靶向治疗药物。该公司提供 SBT8230，用于通过靶向 TLR8 激活到肝脏，诱导抗病毒免疫反应来治疗慢性乙型肝炎病毒感染。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than Silverback Therapeutics</li>
<li>TSX Venture Exchange (Formerly Canadian Venture Exchange)</li>
<li>Merck: 4 No-Brainer Reasons to Buy This Dip</li>
<li>Find and Profitably Trade Stocks at 52-Week Lows</li>
<li>Ackman Announces Major Stake in Uber: Should You Follow His Lead?</li>
<li>What Are the FAANG Stocks and Are They Good Investments?</li>
<li>Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票超过银背生物科技</li>
<li>TSX 风险投资交易所（前身为加拿大风险投资交易所）</li>
<li>默克：购买此跌幅的四个不容错过的理由</li>
<li>寻找并盈利交易 52 周低点的股票</li>
<li>阿克曼宣布在优步的重大股份：你应该跟随他的脚步吗？</li>
<li>FAANG 股票是什么，它们是好的投资吗？</li>
<li>富国银行升级了这三只股票——它们为何脱颖而出</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如有任何问题或意见，请发送至 contact@marketbeat.com.</em></p>
</div><h2>Where Should You Invest $1,000 Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元吗？</h2>
</div><p>Before you make your next trade, you'll want to hear this.</p>
<div class="lb-trans"><p>在你进行下一笔交易之前，你会想听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。</p>
</div><p>Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list.</p>
<div class="lb-trans"><p>我们的团队已确定五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而且没有大名鼎鼎的股票在名单上。</p>
</div><p>They believe these five stocks are the five best companies for investors to buy now...</p>
<div class="lb-trans"><p>他们认为这五只股票是投资者现在购买的五家最佳公司……</p>
</div><p>See The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div><h2>Should You Invest $1,000 in Silverback Therapeutics Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在银背生物科技吗？</h2>
</div><p>Before you consider Silverback Therapeutics, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑银背生物科技之前，你会想听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Silverback Therapeutics wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已确定五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而银背生物科技并不在名单上。</p>
</div><p>While Silverback Therapeutics currently has a &#34;Hold&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然银背生物科技目前在分析师中有 “持有” 评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

Silverback Therapeutics（纳斯达克股票代码：SBTX）股价下跌 6.9% - 以下是原因